1448 related articles for article (PubMed ID: 26484874)
1. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.
Harnan SE; Tappenden P; Essat M; Gomersall T; Minton J; Wong R; Pavord I; Everard M; Lawson R
Health Technol Assess; 2015 Oct; 19(82):1-330. PubMed ID: 26484874
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two exhaled nitric oxide analyzers: the NIOX MINO hand-held electrochemical analyzer and the NOA280i stationary chemiluminescence analyzer.
Kim SH; Moon JY; Kwak HJ; Kim SI; Park DW; Kim JW; Kim TH; Sohn JW; Shin DH; Park SS; Yoon HJ
Respirology; 2012 Jul; 17(5):830-4. PubMed ID: 22404295
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fractional exhaled nitric oxide levels measured by different analyzers produced by different manufacturers.
Saito J; Kikuchi M; Fukuhara A; Sato S; Rikimaru M; Suzuki Y; Uematsu M; Fukuhara N; Kawamata T; Umeda T; Togawa R; Sato Y; Koizumi T; Hirai K; Minemura H; Nikaido T; Kanazawa K; Tanino Y; Shibata Y; Munakata M
J Asthma; 2020 Nov; 57(11):1216-1226. PubMed ID: 31288573
[No Abstract] [Full Text] [Related]
4. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom.
Price D; Berg J; Lindgren P
Allergy; 2009 Mar; 64(3):431-8. PubMed ID: 19183419
[TBL] [Abstract][Full Text] [Related]
5. Difference between two exhaled nitric oxide analyzers, NIOX VERO
Tanabe Y; Harada N; Ito J; Matsuno K; Takeshige T; Harada S; Takemasa M; Kotajima M; Ishimori A; Katsura Y; Makino F; Atsuta R; Takahashi K
J Asthma; 2019 Feb; 56(2):167-172. PubMed ID: 30335533
[TBL] [Abstract][Full Text] [Related]
6. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.
Fraser H; Gallacher D; Achana F; Court R; Taylor-Phillips S; Nduka C; Stinton C; Willans R; Gill P; Mistry H
Health Technol Assess; 2020 Jun; 24(31):1-232. PubMed ID: 32605705
[TBL] [Abstract][Full Text] [Related]
7. [Agreement between two devices for measuring exhaled nitric oxide].
Sardón Prado O; Aldasoro Ruiz A; Korta Murua J; Mintegui Aramburu J; Emparanza Knorr JI; Pérez-Yarza EG
An Pediatr (Barc); 2007 Dec; 67(6):572-7. PubMed ID: 18053523
[TBL] [Abstract][Full Text] [Related]
8. Can we use portable nitric oxide analyzer in young children?
Kalliola S; Malmberg P; Rito T; Pelkonen AS; Mäkelä MJ
Pediatr Pulmonol; 2011 Jul; 46(7):627-31. PubMed ID: 21634029
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C
Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198
[TBL] [Abstract][Full Text] [Related]
11. Exhaled nitric oxide levels to guide treatment for children with asthma.
Petsky HL; Kew KM; Chang AB
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011439. PubMed ID: 27825189
[TBL] [Abstract][Full Text] [Related]
12. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
[TBL] [Abstract][Full Text] [Related]
13. Reliability of a new hand-held device for the measurement of exhaled nitric oxide.
Khalili B; Boggs PB; Bahna SL
Allergy; 2007 Oct; 62(10):1171-4. PubMed ID: 17845587
[TBL] [Abstract][Full Text] [Related]
14. Measurement of Fractional Exhaled Nitric Oxide in Adults: Comparison of Two Different Analyzers (NIOX VERO and NObreath).
Kang SY; Lee SM; Lee SP
Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):182-187. PubMed ID: 33691356
[TBL] [Abstract][Full Text] [Related]
15. Fractional exhaled nitric oxide: comparison between portable devices and correlation with sputum eosinophils.
Yune S; Lee JY; Choi DC; Lee BJ
Allergy Asthma Immunol Res; 2015 Jul; 7(4):404-8. PubMed ID: 25749783
[TBL] [Abstract][Full Text] [Related]
16. Measurement of fractional exhaled nitric oxide by a new portable device: comparison with the standard technique.
Pisi R; Aiello M; Tzani P; Marangio E; Olivieri D; Chetta A
J Asthma; 2010 Sep; 47(7):805-9. PubMed ID: 20670207
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
[TBL] [Abstract][Full Text] [Related]
18. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
